Detalles de la búsqueda
1.
Avanzando Caminos (Leading Pathways): Design and Procedures of The Hispanic/Latino Cancer Survivorship Study.
Am J Epidemiol
; 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38576195
2.
The Effect of Disability and Social Determinants of Health on Breast and Cervical Cancer Screenings During the COVID-19 Pandemic.
Prev Chronic Dis
; 21: E05, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38271492
3.
Development of a multigenerational digital lifestyle intervention for women cancer survivors and their families.
Psychooncology
; 29(1): 182-194, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31600424
4.
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer.
Breast Cancer Res
; 20(1): 52, 2018 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29898752
5.
Cerebrospinal Fluid Testing in Leptomeningeal Progression of HER2-Negative Breast Cancer Reveals HER2 Positivity, Leading to HER2-Targeted Therapy: A Case Report.
Cureus
; 16(3): e55483, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38571852
6.
Triple Primary Cancers: An Analysis of Genetic and Environmental Factors.
Cancer Prev Res (Phila)
; 17(5): 209-215, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361103
7.
Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
JCO Precis Oncol
; 8: e2300513, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38354330
8.
Symptoms and Needs Monitoring in Diverse Ambulatory Oncology Patients: Usage Characteristics and Impact on Emergency Room Visits and Hospitalization.
J Clin Oncol
; 41(2): 285-294, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36219817
9.
Factors Associated With Unmet Supportive Care Needs and Emergency Department Visits and Hospitalizations in Ambulatory Oncology.
JAMA Netw Open
; 6(6): e2319352, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37342038
10.
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
J Clin Oncol
; 41(33): 5140-5150, 2023 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37561967
11.
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
JCO Precis Oncol
; 7: e2300385, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096472
12.
Implementation and Feasibility of an Electronic Health Record-Integrated Patient-Reported Outcomes Symptom and Needs Monitoring Pilot in Ambulatory Oncology.
JCO Oncol Pract
; 18(7): e1100-e1113, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35290096
13.
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
JCO Precis Oncol
; 6: e2200191, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36409971
14.
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
J Clin Oncol
; 39(22): 2443-2451, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33844595
15.
Palbociclib in Patients With Non-Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
JCO Precis Oncol
; 4: 757-766, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35050752
16.
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Target Oncol
; 15(6): 733-741, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33090333
17.
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07).
Nat Commun
; 11(1): 5824, 2020 11 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33203854
18.
Ocular involvement as the initial manifestation of T-cell chronic lymphocytic leukemia.
Am J Ophthalmol
; 144(2): 326-9, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17659976
19.
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain.
Cancer Res
; 76(13): 3702-10, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27197192
20.
Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response.
Cancer Res
; 70(24): 10121-30, 2010 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21159634
Resultados
1 -
20
de 20
1
Próxima >
>>